Found 13 matching trials
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
PHASE2The main purpose of this study is to evaluate the safety of each study vacc...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
PHASE2The purpose of the study is to find out if an investigational drug called D...
Location
Moffitt Cancer Center
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
N/AImmune-based therapies (vaccines) are a new focus of clinical investigation...
Status
No Longer Available
Location
Hospital of the University of Pennsylvania
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer
PHASE1This is a pilot study to determine feasibility and safety of the combinatio...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
DC Vaccine for Patients With Ductal Carcinoma In Situ
PHASE1Women who are diagnosed with Her-2/neu over-expressing DCIS will receive DC...
Location
Hospital of the University of Pennsylvania
DC1s-CTL Cellular Therapy for Renal Cell Carcinoma
PHASE1This trial is to evaluate the safety and effectiveness of autologous type-1...
Location
Multiple Locations
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
PHASE2The purpose of this study is to learn more about how to treat patients with...
Location
H. Lee Moffitt Cancer Center and Research Institute
A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
PHASE1The purpose of the study is to treat patients with Ductal carcinoma in situ...
Location
H. Lee Moffitt Cancer Center and Research Institute
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
PHASE1The purpose of this study is to learn about the effects of the study treatm...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
PHASE1The purpose of this study is to test the safety of Adoptive T-Cell therapy ...
Location
Moffitt Cancer Center